VIN usual type - From the past to the future

Mario Preti, Sarah Igidbashian, Silvano Costa, Paolo Cristoforoni, Luciano Mariani, Massimo Origoni, Maria T. Sandri, Sara Boveri, Noemi Spolti, Laura Spinaci, Francesca Sanvito, Eleonora P. Preti, Adriana Falasca, Gianluigi Radici, Leonardo Micheletti

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Usual vulvar intraepithelial neoplasia (uVIN) is the most common VIN type, generally related to a human papillomavirus (HPV) infection, predominantly type 16. The incidence of uVIN has been increasing over the last decades, and a bimodal peak is observed at the age of 40-44 and over 55 years. Almost 40% of patients with uVIN have a past, concomitant or future HPV-associated lesion of the lower genital tract. HPV-related malignancies are associated with a persistent HPV infection. The host immune response is of crucial importance in determining clearance or persistence of both HPV infections and HPV-related VIN. About 60% of the patients present with symptoms. Clinical features of uVIN vary in site, number, size, shape, colour, and thickness of lesions. Multicentric disease is often present. Most uVIN lesions are positive at immunohistochemistry to p16ink4a and p14arf, but negative to p53.

Original languageEnglish
Article number531
Journalecancermedicalscience
Volume9
DOIs
Publication statusPublished - Apr 29 2015

Fingerprint

Papillomavirus Infections
Neoplasms
Tumor Suppressor Protein p14ARF
Color
Immunohistochemistry
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Preti, M., Igidbashian, S., Costa, S., Cristoforoni, P., Mariani, L., Origoni, M., ... Micheletti, L. (2015). VIN usual type - From the past to the future. ecancermedicalscience, 9, [531]. https://doi.org/10.3332/ecancer.2015.531

VIN usual type - From the past to the future. / Preti, Mario; Igidbashian, Sarah; Costa, Silvano; Cristoforoni, Paolo; Mariani, Luciano; Origoni, Massimo; Sandri, Maria T.; Boveri, Sara; Spolti, Noemi; Spinaci, Laura; Sanvito, Francesca; Preti, Eleonora P.; Falasca, Adriana; Radici, Gianluigi; Micheletti, Leonardo.

In: ecancermedicalscience, Vol. 9, 531, 29.04.2015.

Research output: Contribution to journalArticle

Preti, M, Igidbashian, S, Costa, S, Cristoforoni, P, Mariani, L, Origoni, M, Sandri, MT, Boveri, S, Spolti, N, Spinaci, L, Sanvito, F, Preti, EP, Falasca, A, Radici, G & Micheletti, L 2015, 'VIN usual type - From the past to the future', ecancermedicalscience, vol. 9, 531. https://doi.org/10.3332/ecancer.2015.531
Preti M, Igidbashian S, Costa S, Cristoforoni P, Mariani L, Origoni M et al. VIN usual type - From the past to the future. ecancermedicalscience. 2015 Apr 29;9. 531. https://doi.org/10.3332/ecancer.2015.531
Preti, Mario ; Igidbashian, Sarah ; Costa, Silvano ; Cristoforoni, Paolo ; Mariani, Luciano ; Origoni, Massimo ; Sandri, Maria T. ; Boveri, Sara ; Spolti, Noemi ; Spinaci, Laura ; Sanvito, Francesca ; Preti, Eleonora P. ; Falasca, Adriana ; Radici, Gianluigi ; Micheletti, Leonardo. / VIN usual type - From the past to the future. In: ecancermedicalscience. 2015 ; Vol. 9.
@article{ce8f45c1d7cb4dadb3c326e9b44caf1f,
title = "VIN usual type - From the past to the future",
abstract = "Usual vulvar intraepithelial neoplasia (uVIN) is the most common VIN type, generally related to a human papillomavirus (HPV) infection, predominantly type 16. The incidence of uVIN has been increasing over the last decades, and a bimodal peak is observed at the age of 40-44 and over 55 years. Almost 40{\%} of patients with uVIN have a past, concomitant or future HPV-associated lesion of the lower genital tract. HPV-related malignancies are associated with a persistent HPV infection. The host immune response is of crucial importance in determining clearance or persistence of both HPV infections and HPV-related VIN. About 60{\%} of the patients present with symptoms. Clinical features of uVIN vary in site, number, size, shape, colour, and thickness of lesions. Multicentric disease is often present. Most uVIN lesions are positive at immunohistochemistry to p16ink4a and p14arf, but negative to p53.",
author = "Mario Preti and Sarah Igidbashian and Silvano Costa and Paolo Cristoforoni and Luciano Mariani and Massimo Origoni and Sandri, {Maria T.} and Sara Boveri and Noemi Spolti and Laura Spinaci and Francesca Sanvito and Preti, {Eleonora P.} and Adriana Falasca and Gianluigi Radici and Leonardo Micheletti",
year = "2015",
month = "4",
day = "29",
doi = "10.3332/ecancer.2015.531",
language = "English",
volume = "9",
journal = "ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",

}

TY - JOUR

T1 - VIN usual type - From the past to the future

AU - Preti, Mario

AU - Igidbashian, Sarah

AU - Costa, Silvano

AU - Cristoforoni, Paolo

AU - Mariani, Luciano

AU - Origoni, Massimo

AU - Sandri, Maria T.

AU - Boveri, Sara

AU - Spolti, Noemi

AU - Spinaci, Laura

AU - Sanvito, Francesca

AU - Preti, Eleonora P.

AU - Falasca, Adriana

AU - Radici, Gianluigi

AU - Micheletti, Leonardo

PY - 2015/4/29

Y1 - 2015/4/29

N2 - Usual vulvar intraepithelial neoplasia (uVIN) is the most common VIN type, generally related to a human papillomavirus (HPV) infection, predominantly type 16. The incidence of uVIN has been increasing over the last decades, and a bimodal peak is observed at the age of 40-44 and over 55 years. Almost 40% of patients with uVIN have a past, concomitant or future HPV-associated lesion of the lower genital tract. HPV-related malignancies are associated with a persistent HPV infection. The host immune response is of crucial importance in determining clearance or persistence of both HPV infections and HPV-related VIN. About 60% of the patients present with symptoms. Clinical features of uVIN vary in site, number, size, shape, colour, and thickness of lesions. Multicentric disease is often present. Most uVIN lesions are positive at immunohistochemistry to p16ink4a and p14arf, but negative to p53.

AB - Usual vulvar intraepithelial neoplasia (uVIN) is the most common VIN type, generally related to a human papillomavirus (HPV) infection, predominantly type 16. The incidence of uVIN has been increasing over the last decades, and a bimodal peak is observed at the age of 40-44 and over 55 years. Almost 40% of patients with uVIN have a past, concomitant or future HPV-associated lesion of the lower genital tract. HPV-related malignancies are associated with a persistent HPV infection. The host immune response is of crucial importance in determining clearance or persistence of both HPV infections and HPV-related VIN. About 60% of the patients present with symptoms. Clinical features of uVIN vary in site, number, size, shape, colour, and thickness of lesions. Multicentric disease is often present. Most uVIN lesions are positive at immunohistochemistry to p16ink4a and p14arf, but negative to p53.

UR - http://www.scopus.com/inward/record.url?scp=84934901447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934901447&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2015.531

DO - 10.3332/ecancer.2015.531

M3 - Article

AN - SCOPUS:84934901447

VL - 9

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

M1 - 531

ER -